The addition of the glucagon receptor in Retatrutide introduces a unique safety variable: a temporary spike in resting heart rate that peaks around week 24 before gradually declining
Immune System Findings from multiple studies have demonstrated that GLP-1 also regulates the immune system
1 Further, those living with T2DM have a large array of therapeutic options for controlling blood glucose beyond exogenous insulin, and more opportunities exist for evaluating the CV safety of therapies in this patient population
Aim for 0.7-1.0 grams of protein per pound of ideal body weight daily
Preparing for Increased Use With millions of patients taking GLP-1 medications, including semaglutide, tirzepatide, liraglutide, and dulaglutide, dental teams will encounter these therapies more frequently in practice
Hormonal Imbalances Beyond thyroid, other hormonal imbalances affect weight regulation